Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve ...
Aptevo Therapeutics (NASDAQ:APVO) announced two additional frontline Acute Myeloid Leukemia (AML) patients have achieved ...